PRNP and Alzheimer disease: Additionally, Zafar et al. (2017) demonstrated a significant 1.2-fold decrease in the levels of diglycosylated PrPC isoforms in rapidly progressive AD (rpAD) patients compared to controls but significantly increased total PrPC levels in slow progressive AD (spAD) and rpAD patients.